CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

NUVAXOVID

RegulatoryapprovedNUVAXOVIDPositive
AI Analysis

Summary

NUVAXOVID is approved for active immunization to prevent COVID-19 in individuals 65 years and older and those 12-64 years of age. This is a routine regulatory update regarding an already-approved vaccine.

Outcome Details

Approved for use in individuals 65 years of age and older, and 12 years through 64 years of age

Importance:3/10
Sentiment:
0.50
COVID-19vaccineFDA approvalimmunization
Related Companies

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on August 27, 2026 10:12 PM

Read Original